Showing 61-70 of 1477 results for "".
Conversations on Early Intervention and Postop Glaucoma Complications
https://modernod.com/podcasts/the-mod-pod/conversations-on-early-intervention-and-postop-glaucoma-complications/36855/Happy New Year! Enjoy The MOD Pod's new format. You'll still get a recap of selected articles from the latest issue of Modern Optometry, but instead of hearing them being read by the authors, you get a lively discussion between the podcast's new host, Cecelia Koetting, OD, FAAO, Dipl ABO, and the auEarlier Comanagement of Today’s Glaucoma Patient
https://modernod.com/mod-issues/supplements-inserts/earlier-comanagement-of-todays-glaucoma-patient/38501/[Genetics and Eyecare Today] The Role of Genetic Testing and Early Keratoconus Diagnosis
https://modernod.com/podcasts/the-mod-pod/genetics-and-eyecare-today-the-role-of-genetic-testing-and-early-keratoconus-diagnosis/36807/In another special edition episode of The MOD Pod's mini-series Genetics and Eyecare Today, Drs. John Gelles and William Trattler talk about corneal collagen cross-linking and distinguishing between a patient with progressive myopia or developing keratoconus. Drs. Gelles and Trattler also discuss thSlow AMD Progression
https://modernod.com/topics/retina/slow-amd-progression/38529/Early detection continues to be essential in preserving patients’ vision.Retina Specialist Perspectives
https://modernod.com/specialty/retina/Retina-Specialist-Perspectives-2506/33191/Retina specialists share collaborative care strategies to achieve the best outcomes for patients with retinal disease. <Why It’s Important to Have an OCT in Your Practice
https://modernod.com/topics/imagingdiagnostics/why-its-important-to-have-an-oct-in-your-practice/38718/This diagnostic device may require a clinician’s interpretation, but it enables the early detection of disease and can in some cases save a patient’s vision.Achieving Durable Outcomes in Treatment-Naïve nAMD
https://modernod.com/specialty/retina/Achieving-Durable-Outcomes-in-treatment-naive-nAMD-2506/33189/Drs. Garg and Wykoff discuss a treatment-naïve patient with neovascular age-related macular degeneration and the impact of second-generation agents.Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
https://modernod.com/cme/ophthalmology/Sustaining-Vision-Empowering-Optometry-for-Tomorrows-Retinal-Care/32392/Join Drs. Khanani, Sheth, and Vajzovic, to learn how to educate patients about alternative treatment options for retinal diseases.New Drugs for Dry Eye and Demodex Blepharitis
https://modernod.com/topics/ocular-surface/new-drugs-for-dry-eye-and-idemodexi-blepharitis/38625/More options, more personalized treatment for patients. Get familiar with what may end up in your toolbox.The Near Future in Managing Dry Eye Disease
https://modernod.com/mod-issues/marchapril-2025-supplement/the-near-future-in-managing-dry-eye-disease/38940/A closer look at the biggest challenges in treating DED and what’s in the pipeline.